Primary Care

Novartis ups marketing investment in Entresto, by $200 million

Novartis ups marketing investment in Entresto, by $200 million

By

One oft-cited challenge to Entresto's adoption has been prior authorization requirements.

OPINION

Gottlieb Likely to Take On Off-Label, Predictability at the FDA

Newsletters